CCM
FENC icon

Cadence Capital Management’s Fennec Pharmaceuticals FENC Stock Holding History

Cadence Capital Management’s Portfolio FENC Stock Details FENC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		$215K Sell
35,536
-118,020
-77% -$832K 0.05% 268
2020
Q2 		$1.28M Buy
153,556
+6,448
+4% +$48K 0.19% 172
2020
Q1 		$874K Buy
+147,108
New +$959K 0.15% 221

Other funds holding FENC

SCA
Southpoint Capital Advisors New York $4.86B AUM 34.09% 1-Year Est. Return
ACA
Avoro Capital Advisors New York $10.2B AUM 149.19% 1-Year Est. Return
SFI
Sonic Fund II Honolulu, Hawaii $147M AUM 19.98% 1-Year Est. Return
EAM
Eventide Asset Management Boston, Massachusetts $6.05B AUM 76.64% 1-Year Est. Return
6CM
683 Capital Management New York $1.92B AUM 85.52% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
SCM
Solas Capital Management Darien, Connecticut $174M AUM 6.33% 1-Year Est. Return
GIM
Granahan Investment Management Waltham, Massachusetts $2.07B AUM 56.45% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Russell Investments Group
Russell Investments Group London, United Kingdom $93.1B AUM 28.26% 1-Year Est. Return

Cadence Capital Management's FENC Position: Q3 2020 in Review

Cadence Capital Management reduced its Fennec Pharmaceuticals (FENC) stake by 77% in Q3 2020, selling an estimated $832K and leaving 35,536 shares worth $215K. The position accounts for 0.05% of the portfolio, ranked #268.

Cadence Capital Management first reported a position in FENC in Q1 2020 and has held it in 3 quarters since. The position peaked at $1.28M in Q2 2020. 55 funds tracked by Wall St. Rank hold FENC as of Q3 2020.

  • Cadence Capital Management held 35,536 shares of Fennec Pharmaceuticals worth $215K as of Q3 2020.
  • Cadence Capital Management sold 118,020 Fennec Pharmaceuticals shares in Q3 2020, an estimated $832K.
  • Fennec Pharmaceuticals made up 0.05% of Cadence Capital Management's portfolio in Q3 2020, its #268 holding.
  • Cadence Capital Management first reported a position in Fennec Pharmaceuticals in Q1 2020 and has held it in 3 quarters since.
  • Cadence Capital Management's Fennec Pharmaceuticals position peaked at $1.28M in Q2 2020.
  • 55 funds tracked by Wall St. Rank held Fennec Pharmaceuticals as of Q3 2020.

Based on Cadence Capital Management's 13F filing for Q3 2020, filed 16 Oct 2020.